EcoDrugPlus

Glutamate Metabotropic Receptor 2

Ensembl ID : ENSOTSG00005014443
Gene Symbol: GRM2
3 Cross references
201 Possible Orthologues:

Glutamate Metabotropic Receptor 4

Ensembl ID : ENSOTSG00005001351
Gene Symbol: GRM4
1 Cross references
203 Possible Orthologues:

Glutamate Metabotropic Receptor 4

Ensembl ID : ENSOTSG00005042362
Gene Symbol: GRM4
3 Cross references
190 Possible Orthologues:

Glutamate Metabotropic Receptor 4

Ensembl ID : ENSOTSG00005018874
Gene Symbol: GRM4
1 Cross references
190 Possible Orthologues:

Glutamate Metabotropic Receptor 4

Ensembl ID : ENSOTSG00005041557
Gene Symbol: GRM4
3 Cross references
203 Possible Orthologues:

Glutamate Receptor 1-Like

Ensembl ID : ENSOTSG00005037872
Gene Symbol: LOC112234658
3 Cross references
242 Possible Orthologues:

Glutamate Receptor 1-Like

Ensembl ID : ENSOTSG00005037714
Gene Symbol: LOC112234658
3 Cross references
242 Possible Orthologues:

Glutamate Receptor 2-Like

Ensembl ID : ENSOTSG00005044922
Gene Symbol: LOC112256336
3 Cross references
204 Possible Orthologues:

Glutamate Receptor 3

Ensembl ID : ENSOTSG00005045338
Gene Symbol: LOC112228661
3 Cross references
245 Possible Orthologues:

Glutamate Receptor Ionotropic, Nmda 1

Ensembl ID : ENSOTSG00005033835
Gene Symbol: LOC112233464
3 Cross references
199 Possible Orthologues:

Glutamate Receptor Ionotropic, Nmda 1

Ensembl ID : ENSOTSG00005000582
Gene Symbol: LOC112248914
3 Cross references
151 Possible Orthologues:

Glutamate Receptor Ionotropic, Nmda 1-Like

Ensembl ID : ENSOTSG00005002272
Gene Symbol: LOC112219354
3 Cross references
198 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).